期刊文献+

维吾尔族特发性膜性肾病患者血清抗PLA2R抗体表达的观察 被引量:1

Differences in serum anti-PLA2R antibody determination in Uygur patients with idiopathic membranous nephropathy in Xinjiang
下载PDF
导出
摘要 目的检测维吾尔族特发性膜性肾病(IMN)患者中血清抗PLA2R抗体测定的灵敏度及特异度,了解维吾尔族IMN患者中血清抗PLA2R抗体能否作为一项生物学标记物。方法收集2016年11月至2017年5月新疆维吾尔自治区人民医院肾病科经肾活检明确诊断为IMN的维吾尔族患者29例作为IMN组,以及维吾尔族非IMN患者(包括IgA肾病,微小病变,局灶阶段肾小球硬化,系膜增生性肾小球肾炎等)29例作为非IMN组,抽取入院第2天晨起空腹血,行血清抗PLA2R抗体检测,收集基线资料、实验临床资料及数据,绘制ROC曲线。结果 IMN组血清抗PLA2R抗体阳性率为58.62%(17例),非IMN组中阳性率为0,在维吾尔族IMN患者中血清抗PLA2R抗体灵敏度为58.62%,特异度为100%,95%置信区间为[95%CI 69.8~93.9],阳性预测值100%,阴性预测值70.73%。符合率为79.31%。结论血清抗PLA2R抗体可作为检测维吾尔族IMN的生物学标志物,维吾尔族IMN患者中抗PLA2R抗体灵敏度及特异度与其它民族可能存在差异。 Objective To detect the sensitivity and specificity of anti-PLA2 R antibodies in Uygur patient with idiopathic membranous nephropathy(IMN),understand whether the serum anti-PLA2 R antibody can be regarded as the biomarker in Uygur patients with IMN,then study whether there are differences in the expression of anti-PLA2 R antibody between Uygurs and other nationalities.Methods The clinic data of 29 IMN patients(test group)and 29 non-IMN patients(control group)in Uygurfrom November 2016 to May 2017 were collected.IMN was diagnosed by renal puncture biopsy.In the control group,there was IgA nephropathy,minimal lesion,focal periodic glomerular sclerosis and mesangial proliferative glomerulonephritis.The fasting blood in the morning was taken out on the second day after admission.The serum antiPLA2 R antibody was detected.Clinical data were estimated by ROC curve.Results The positive rate of anti-PLA2 R antibody in the test group was 58.62%(n=17/29),and that in the control group was 0.The sensitivity and specificity of serum anti-PLA2 R antibody in Uygur patients with IMN were 58.62% and 100%,95% confidence was[68.9-93.9],the positive predictive value was 100%,negative predictive value was 70.73%,and the coincidence was 79.31%.Conclusions The serum anti-PLA2 R antibody can be regarded as the biomarker in Uygur patients with IMN.The sensitivity and specificity of serum anti-PLA2 R antibody in Uygur patients with IMN may differ from those in other nationalities.
作者 张锦 陆晨 张晶晶 ZHANG Jin;LU Chen;ZHANG Jing-jing(Medical College of Shihezi Universit;Shihezi 832002,China)
出处 《临床肾脏病杂志》 2018年第5期263-267,共5页 Journal Of Clinical Nephrology
基金 国家自然科学基金(No.81560121)
关键词 维吾尔族 特发性膜性肾病 抗PLA2R抗体 灵敏度 特异度 Uygur Idiopathic membranous nephropathy Anti-PLA2R antibody Sensitivity Specificity
  • 相关文献

参考文献2

二级参考文献19

  • 1Wasserstein AG.Membranous glomerulonephritis.J Am Soc Nephrol,1997,8:664-674.
  • 2Li LS,Liu ZH.Epidemiologic data of renal diseases from a single unit in China:analysis based on 13,519 renal biopsies.Kidney Int,2004,66:920-923.
  • 3Ponticelli C.Membranous nephropathy.J Nephrol,2007,20:268-287.
  • 4Beck LH Jr,Bonegio RG,Lambeau G,et al.M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.N Engl J Med,2009,361:11-21.
  • 5Salant DJ,Cybulsky AV.Experimental glomerulonephritis.Methods Enzymol,1988,162:421-461.
  • 6Qin W,Beck LH Jr,Zeng C,et al.Anti-phospholipase A2 receptor antibody in membranous nephropathy.J Am Soc Nephrol,2011,22:1137-1143.
  • 7Debiec H,Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.N Engl J Med,2011,364:689-690.
  • 8Ronco P, Debiec H. Pathogenesis of membranous nephropathy: recent advances and future challenges [J]. Nat Rev Nephrol, 2012, 8(4): 203- 213.
  • 9Glassock RJ. The pathogenesis of membranous nephropathy: evolution and revolution [J]. Curr Opin Nephrol Hypertens, 2012, 21(3): 235- 242.
  • 10Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy [J].J Am Soc Nephrol, 2014, 25(6): 1357- 1366.

共引文献75

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部